Skip to main content

Advertisement

SpringerLink
Log in

Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined

  • Research Article
  • Published:
Tumor Biology

Abstract

Although nodal invasion represents one of the most powerful prognostic indicators in colorectal cancer (CRC), marked heterogeneity exists within stage III patients. Lymph node ratio (LNR) may offer more precise prognostication in stage III CRC. The aim of this study is to investigate the prognostic impact of LNR on survival in stage III CRC patients. We retrospectively reviewed the data of 288 consecutive patients who underwent radical resection for stage III CRC between January 2000 and December 2008 in the Gastrointestinal Surgery Department, Peking University People’s Hospital. The patients were divided into three groups according to LNR quartiles: LNR < 0.167 (n = 72), 0.167 ≤ LNR < 0.562 (n = 140), and LNR ≥ 0.562 (n = 76). The association between overall survival (OS) and disease-free survival (DFS) and 11 variables including age, gender, tumor location, size, grade, histology, tumor (T) stage, number of metastatic LNs, and LNR was analyzed by multivariate analysis. Survival curves were plotted by the Kaplan-Meier method. Both LNR and the number of metastatic LNs were significant prognostic factors for 5-year DFS and OS in stage III CRC patients. LNR was an independent prognostic factor for 5-year OS. LNR remained an independent prognostic factor in patients with fewer than 12 lymph nodes examined. LNR was a potent independent prognostic predictor for OS and DFS in stage III CRC patients, especially for patients with fewer than 12 lymph nodes examined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2013;63(2):11–30.

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2008;58(2):71–96.

    Article  PubMed  Google Scholar 

  3. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–5.

    Article  PubMed  Google Scholar 

  4. Greene FL, Page DL, Fleming ID. American joint committee on cancer staging manual. 6th ed. New York: Springer; 2002.

    Book  Google Scholar 

  5. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9.

    Article  PubMed  Google Scholar 

  6. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: a systematic review. J Natl Cancer Inst. 2007;99:433–41.

    Article  PubMed  Google Scholar 

  7. Kim KH, Yang SS, Yoon YS, et al. Validation of the seventh edition the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical center in Korea. Colorectal Dis. 2011;13:220–6.

    Article  Google Scholar 

  8. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.

    Article  PubMed  Google Scholar 

  9. Sobin L, Gospodarowicz M, Wittekind C. TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009.

    Google Scholar 

  10. Polignano F, Henderson N, Alishahi SH, Zito A. Laparoscopic colectomy for cancer and adequate lymphadenectomy. Association between survival and number of lymph nodes. Surg Endosc. 2006;20:996–7.

    Article  CAS  PubMed  Google Scholar 

  11. Rodriguez Santiago JM, Munoz E, Marti M, et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005;31:59–66.

    Article  CAS  PubMed  Google Scholar 

  12. Voordeckers M, Vinh-Hung V, Van de Steene J, et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol. 2004;70:225–30.

    Article  PubMed  Google Scholar 

  13. Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. J Surg Gynecol Obstet. 1990;170(6):488–94.

    CAS  Google Scholar 

  14. Inoue K, Nakane Y, Liyama H, et al. The superiority of ratio-based lymph-node staging in gastric carcinoma. J Ann Surg Oncol. 2002;9(1):27–34.

    Article  Google Scholar 

  15. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. J Ann Surg Oncol. 2002;9(6):775–84.

    Article  Google Scholar 

  16. Berger AC, Watson JC, Ross EA, et al. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Am Surg. 2004;70(3):235–40.

    Google Scholar 

  17. Rausei S et al. Impact of lymph node ratio on survival of colorectal cancer patients. Int J Surg. 2013;11:95–9.

    Article  Google Scholar 

  18. Lee SD, Kim TH, Kim DY, et al. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. J of Cancer Surg. 2012;38:478–83.

    CAS  Google Scholar 

  19. Madbouly KM, Abbas KS, Hussein AM, et al. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. J Am Surg. 2013;68(4):166–78.

    Google Scholar 

  20. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325–44.

    Article  CAS  PubMed  Google Scholar 

  21. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165–7.

    Article  CAS  PubMed  Google Scholar 

  22. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219–25.

    Article  PubMed  Google Scholar 

  23. Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41:272–9.

    Article  PubMed  Google Scholar 

  24. Wright FC, Law CH, Last L, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol. 2003;10:903–9.

    Article  CAS  PubMed  Google Scholar 

  25. Gorog D, Nagy P, Peter A, et al. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res. 2003;9:180–3.

    Article  PubMed  Google Scholar 

  26. Horzic M, Kopljar M. Minimum number of lymph nodes that need to be examined for adequate staging of colorectal cancer: factors influencing lymph node harvest. Hepatogastroenterol. 2005;52:86–9.

    Google Scholar 

  27. Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum? Virchows Arch. 2003;443:133–8.

    Article  PubMed  Google Scholar 

  28. Peschaud F, Benoist S, Julie C, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. J Ann Surg. 2008;248(6):1067–73.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Surgery, Peking University People’s Hospital, Beijing, 100044, China

    Kewei Jiang, Yi Zhu, Yan Liu, Yingjiang Ye, Qiwei Xie, Xiaodong Yang & Shan Wang

Authors
  1. Kewei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yingjiang Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiwei Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaodong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shan Wang.

Additional information

Kewei Jiang and Yi Zhu contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, K., Zhu, Y., Liu, Y. et al. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined. Tumor Biol. 35, 11685–11690 (2014). https://doi.org/10.1007/s13277-014-2484-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2484-x

Keywords

Search

Navigation